FDA Clears SurGenTec’s Lumbar Facet Fixation System

SurGenTec has secured U.S. Food and Drug Administration (FDA) clearance for its ION-L Lumbar Facet Fixation System. Part of SurGenTec’s facet fixation platform, ION-L is built to treat skeletally mature patients with degenerative disc disease (DDD) from L3 to S1 who have failed conservative care.

ION-L addresses the demands of posterior lumbar facet fixation while minimizing the surgical footprint. Placed bilaterally through a posterior surgical approach, the system spans the facet joint interspace and is engineered for controlled, non-impact insertion to protect surrounding patient anatomy while reducing the need for extensive posterior exposure.

Key design features include:

• Zero-profile implant design
• Fenestrations and open barrels to support bone graft integration and fusion
• Neutral joint positioning to reduce the risk of unintended joint expansion during insertion
• Engagement features designed to resist implant expulsion
• Nanotex surface technology with controlled pore sizes to attract and retain bone marrow aspirate and growth factors to support osseointegration

The ION-L’s clearance is supported by a multicenter clinical study conducted with IRB approval at all sites and conducted by an independent third-party organization. Two radiologists independently reviewed radiographic outcomes to assess fusion outcomes, and no adverse events were reported. The study evaluated a deliberately high-risk, real-world cohort —representing medically complex patients in whom durable lumbar fusion is hardest to achieve.

“ION-L reflects our continued commitment to building a comprehensive facet fixation platform that provides surgeons with consistent, reliable, and less invasive solutions across the spine,” SurGenTec Founder/CEO Travis Greenhalgh said. “For decades, spinal fixation has relied on bulky hardware and invasive techniques. With ION-L, we have demonstrated that surgeons can achieve the same clinical goals through a less invasive, facet-based approach.”

The ION-L kit includes sterile, single-use disposable instruments and sterile, ready-to-use implants, which help mitigate the risk of contamination and eliminate costs associated with reprocessing instruments. Overall, ION-L supports flexible surgical workflows across operating room environments, making it ideal for both hospitals and outpatient ambulatory surgery centers.

SurGenTec develops surgical technologies for spine and orthopedic procedures. The company advances its product portfolio by developing solutions that address the evolving needs of healthcare providers and patients. SurGenTec has recently expanded into international markets, including the opening of its new international sales headquarters in Brazil.